The Leukemia and Lymphoma Society shared a post on LinkedIn:
“Artificial intelligence is transforming healthcare, offering opportunities to streamline processes, enhance diagnoses, and improve patient outcomes. But it also raises critical concerns about privacy, accuracy, and equity.
This topic took center stage at the ASH 2024 Clinicians in Practice luncheon, where patient perspectives highlighted the importance of trust and transparency in AI’s integration into care.
Explore the benefits, challenges, and actionable insights for both patients and healthcare professionals.”
More posts featuring The Leukemia and Lymphoma Society.